The top vaccine and biologics drug official in the U.S. Food and Drug Administration will step down in April. The agency made ...
In early 2026, Moderna reported encouraging long-term data for its personalized cancer vaccine mRNA-4157 (V940) in high-risk melanoma, while the FDA granted expedited review and an August 5, 2026 ...
FDA launches new AI-powered system to track drug and vaccine side effects in real time, replacing outdated databases and saving $120 million annually.
The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second ...
FDA vaccine chief step down in April confirmed as Dr. Vinay Prasad leaves after leading key initiatives at CBER.
The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson ...
Incentives to bring vaccines to market are shrinking. Drugmakers are scaling back research investments and cutting jobs.
The FDA has approved a third respiratory syncytial virus vaccine for high-risk adults aged younger than 50 years — a ...
Public health, explained: Sign up to receive Healthbeat’s free national newsletter here. Six days after a senior Food and Drug Administration official sent a sweeping internal email claiming that ...
Vaccine advisers to the US Food and Drug Administration will meet Thursday to discuss what information the agency should ask for in considering the go-ahead for vaccinating children under 12 -- ...
On March 17, 1995, the FDA approved the first chickenpox vaccine in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results